Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001065774 | SCV001230757 | uncertain significance | Lethal congenital glycogen storage disease of heart | 2019-12-19 | criteria provided, single submitter | clinical testing | This variant has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 16487706). ClinVar contains an entry for this variant (Variation ID: 6856). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces serine with proline at codon 548 of the PRKAG2 protein (p.Ser548Pro). The serine residue is highly conserved and there is a moderate physicochemical difference between serine and proline. This variant is not present in population databases (ExAC no frequency). |
OMIM | RCV000007259 | SCV000027455 | pathogenic | Hypertrophic cardiomyopathy 6 | 2006-03-01 | no assertion criteria provided | literature only |